Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v11-FR
Language French French
Date Updated 2023-05-18 2023-05-12
Drug Identification Number 02514095 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name Diltiazem Hydrochloride Injection Diltiazem Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10 mL vial / fiole 10 x 10 mL vial / fiole
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-05-26 2023-05-19
Actual start date
Estimated end date 2023-07-15 2023-07-15
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments